Molcure IncGerman antibody specialist YUMAB GmbH has inked a collaboration agreement with Japanese MOLCURE Inc aimed at using the company’s zero-shot AI technology for antibody discovery.
Tag Archive for: Drug Discovery
Image by freepikAntimicrobial resistance (AMR) poses a huge threat to the prevention and treatment of a growing number of infections caused by bacteria, parasites, viruses, and fungi. A public-private partnership involving nine European projects and 98 organisations is now calling for long-term investment to maintain Europe’s ability to research and develop new antibiotics.
After the drug discovery specialist Evotec SE lowered its annual forecast and lost almost 75% of its market capitalisation in just eight months, the new CEO, Christian Wojczewski, is taking action and closing non-profitable areas.
Evotec SEEvotec SE is widening its 2022 R&D collaboration SynaptixBio Ltdi to optimise and identify new antisense oligonucleotides to treat children with H-ABC leukodystrophy, a rare genetic myelin synthesis defect that shows similar symptoms such as multiple sclerosis.
Viennese biotech QUANTRO Therapeutics identifies small molecule targeting an onkogenic transcription factor in Boehringer Ingelheim collab.
London-based AI-driven antibody drug discovery specialist LabGenius Ltd has closed a £35m Series B financing round.
Ipsen SA and RNA splicing modifier specialist Skyhawk Therapeutics Inc have entered a US$1.8bn licencing option deal in rare neurological disorders.
Organoid technology has emerged as one of the most groundbreaking and cutting-edge technologies in the biomedical field. It finds widespread applications in disease modeling, drug discovery and screening, companion diagnostics, cell therapy, regenerative medicine, and more.
Belfast-based techbio company AMPLY Discovery Ltd announced today will make use of a £1.4m in grant funding to advance its AI-based drug discovery platform.
Paris-based AI-inspired drug discovery specialist Iktos SA has closed a €15.5m financing to expand its platform and kick-start the new CRO Iktos Robotics.
Tag Archive for: Drug Discovery
In October ELRIG will welcome over 3000 people to Liverpool, UK for Drug Discovery 2025, Europe’s largest conference dedicated to drug discovery in the life sciences community.
Why should you come?
To learn!
With two days of in-depth scientific content covering the full spectrum of the drug discovery and development process, there is something for everyone. Each day there are six parallel scientific tracks, poster sessions and specialist talks, so you can explore your interests and perhaps look for new ideas and technologies to help your research.
To explore!
The exhibition hall is open throughout the conference, with over 200 companies there is no better place to find out what tools and services are available to enable your research. The Tech Theatre hosts sessions on automation, robotics and AI, while the Breakthrough Zone is the space to find the newest innovations from the entrepreneurial exhibitors and tips to help you launch your own company.
To open doors!
ELRIG is expecting over 3000 people to attend Drug Discovery 2025, there are dedicated sessions for those looking for careers advice, flash presentations from the Breakthrough Zone companies and networking opportunities. You never know where a conversation over a coffee might lead.
It’s free!
Though you must register, all ELRIG events are free to attend, encouraging participation from all in the drug discovery community, enabling learning and collaboration across disciplines, academia, and industry.
ELRIG, is a UK-based not-for-profit volunteer-led organisation, dedicated to delivering inspiring events to the dynamic life science community. With a global community of over 22,000 life science professionals across all levels, ELRIG is committed to accessible and inclusive events.
Contact info + URL event website or landing page for registrations
Contact info@elrig.org with enquiries. Register free here- https://bit.ly/3HVBPkX